11/14/2024
5:40 PM | Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G/A | |
11/14/2024
5:57 PM | Adverum Biotechnologies (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G/A | |
11/06/2024
4:49 PM | Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
11/04/2024
3:42 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
3:44 PM | Adverum Biotechnologies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
11:41 AM | Adverum Biotechnologies (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G | |
10/30/2024
8:34 PM | Adverum Biotechnologies (Subject)
Stern Augustus (Filed by)
| Form SC 13G | |
|
10/23/2024
12:34 PM | Adverum Biotechnologies (Subject)
Principia Wealth Advisory, LLC (Filed by)
| Form SC 13G | |
10/22/2024
5:06 PM | Adverum Biotechnologies (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
08/12/2024
3:08 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:10 PM | Adverum Biotechnologies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/22/2024
3:24 PM | Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
07/18/2024
8:16 PM | Adverum Biotechnologies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
8:16 PM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
8:16 PM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/17/2024
3:38 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:47 PM | Adverum Biotechnologies (Issuer)
Svoronos Dawn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:48 PM | Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:48 PM | Adverum Biotechnologies (Issuer)
Hong Soo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:49 PM | Adverum Biotechnologies (Issuer)
Nicholson, C. David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:50 PM | Adverum Biotechnologies (Issuer)
Ozden Rabia Gurses (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:42 PM | Adverum Biotechnologies (Issuer)
Kiss Szilard (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2024
3:43 PM | Adverum Biotechnologies (Issuer)
Kiss Szilard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:43 PM | Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:44 PM | Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:45 PM | Adverum Biotechnologies (Issuer)
Whitcup Scott M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:46 PM | Adverum Biotechnologies (Issuer)
Tuckson Reed Vaughn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:10 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2024
11:15 PM | Adverum Biotechnologies (Filer)
| Form EFFECT | |
03/26/2024
11:15 PM | Adverum Biotechnologies (Filer)
| Form EFFECT | |
03/21/2024
4:24 PM | Adverum Biotechnologies (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/20/2024
4:04 PM | Adverum Biotechnologies (Filer)
| Form 424B3 | |
03/20/2024
3:13 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
6:05 PM | Adverum Biotechnologies (Issuer)
Fischer Laurent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:06 PM | Adverum Biotechnologies (Issuer)
Soparkar Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:07 PM | Adverum Biotechnologies (Issuer)
Seyedkazemi Setareh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:40 PM | Adverum Biotechnologies (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/22/2024
2:47 PM | Adverum Biotechnologies (Subject)
Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
Logos Global Management LP (Filed by)
| Form SC 13G | |
02/21/2024
2:39 PM | Adverum Biotechnologies (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/15/2024
3:17 PM | Adverum Biotechnologies (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
02/14/2024
7:26 PM | Adverum Biotechnologies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
917 Trades… Zero Losses? (Ad) As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid.
Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities.
But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.” Go here to see how you can start accessing these opportunities today |
02/13/2024
6:34 PM | Adverum Biotechnologies (Subject)
BANK OF AMERICA CORP /DE/ (Filed by)
| Form SC 13G/A | |
02/12/2024
9:13 AM | Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
02/09/2024
4:50 PM | Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
4:51 PM | Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:35 AM | Adverum Biotechnologies (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
7:45 AM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
10:36 AM | Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/06/2024
3:47 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
